Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
BLACKROCK INC BLK |
2,234,699 5.600% |
2,234,699 (New Position) |
Filing History |
| 2024-07-29 4:04 pm Purchase |
2024-07-24 | 13G | Verastem, Inc. VSTM |
Stonepine Capital Management, LLC | 2,666,666 6.700% |
2,666,666 (New Position) |
Filing History |
| 2024-02-14 7:31 pm Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 1,529,115 6.100% |
1,529,115 (New Position) |
Filing History |
| 2024-02-14 10:00 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 2,531,829 9.990% |
1,211,173 (+91.71%) |
Filing History |
| 2024-02-14 09:20 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.990% |
2,617,402 (New Position) |
Filing History |
| 2024-02-13 5:01 pm Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
Vivo Opportunity LLC | 1,538,461 6.100% |
1,538,461 (New Position) |
Filing History |
| 2024-02-02 09:49 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
Soleus Capital Master Fund, L.P. | 1,425,634 6.800% |
128,265 (+9.89%) |
Filing History |
| 2023-08-31 5:28 pm Purchase |
2023-08-21 | 13G | Verastem, Inc. VSTM |
ADAGE CAPITAL PARTNERS GP LLC | 1,300,000 5.150% |
1,300,000 (New Position) |
Filing History |
| 2023-08-10 4:39 pm Sale |
2023-07-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 0 0.000% |
-1,345,192 (Position Closed) |
Filing History |
| 2023-07-27 4:30 pm Purchase |
2023-07-26 | 13G | Verastem, Inc. VSTM |
Soleus Capital Master Fund, L.P. | 1,297,369 5.100% |
1,297,369 (New Position) |
Filing History |
| 2023-06-22 5:46 pm Purchase |
2023-06-21 | 13G | Verastem, Inc. VSTM |
Flynn James E | 1,538,461 6.100% |
1,538,461 (New Position) |
Filing History |
| 2023-06-12 4:37 pm Purchase |
2023-05-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 1,345,192 8.000% |
1,345,192 (New Position) |
Filing History |
| 2023-06-05 5:00 pm Purchase |
2023-05-26 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 1,320,656 7.900% |
1,320,656 (New Position) |
Filing History |
| 2023-02-14 5:16 pm Purchase |
2022-12-31 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 1,375,270 7.900% |
1,375,270 (New Position) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 2,249,075 13.500% |
458,106 (+25.58%) |
Filing History |
| 2023-02-13 8:16 pm Purchase |
2022-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 1,674,539 9.990% |
132,359 (+8.58%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Verastem, Inc. VSTM |
BLACKROCK INC BLK |
361,445 2.300% |
-665,910 (-64.82%) |
Filing History |
| 2022-02-14 4:16 pm Purchase |
2021-12-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 1,790,969 11.800% |
233,828 (+15.02%) |
Filing History |
| 2022-02-10 08:42 am Sale |
2021-12-31 | 13G | Verastem, Inc. VSTM |
The Vanguard Group | 737,483 4.860% |
-13,565 (-1.81%) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Verastem, Inc. VSTM |
BLACKROCK INC BLK |
1,027,354 6.800% |
-96,956 (-8.62%) |
Filing History |